It is white solid in appearance, CAS number is 179324-69-7, and the molecular formula is C19H25BN4O4.

Market Analysis and Insights: Global Bortezomib API Market
The global Bortezomib API market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Bortezomib API Scope and Market Size
The global Bortezomib API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bortezomib API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %

Segment by Application
Injection
Other

The Bortezomib API market is analysed and market size information is provided by regions (countries). Segment by Application, the Bortezomib API market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Scion Pharm Taiwan
Farmhispania Group
Tapi Teva
Shilpa Medicare Limited
Dr. Reddy's Laboratories
Gland Chemicals
Icrom
Vinkem Labs
Qilu Pharmaceutial
Chem-Stone(Guangzhou)
Chengdu Aslee Biopharmaceuticals
Coresyn
Hubei Honch Pharmaceutical